Back
Nuveen Pennsylvania Quality Municipal Income Fund Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
25
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
Last Price:
$12.02
Seasonality Move:
1.8%
Buy
57
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$536.81
Seasonality Move:
15.11%
Sell
25
Nuveen Pennsylvania Quality Municipal Income Fund (NQP)
is a Sell
Is Nuveen Pennsylvania Quality Municipal Income Fund a Buy, Sell or Hold?
-
The current Nuveen Pennsylvania Quality Municipal Income Fund [NQP] share price is $12.03. The Score for NQP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NQP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $546.19. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NQP Stock Price Chart
What is Nuveen Pennsylvania Quality Municipal Income Fund's stock price today?
-
The Nuveen Pennsylvania Quality Municipal Income Fund share price today is $12.03The current trend is moderately bearish and NQP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $546.19The current trend is moderately bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
NQP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 43.89 | Sell |
| Chaikin Money Flow: | 104200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.07 - 12.17) | Sell |
| Bollinger Bands (100): | (11.15 - 12.19) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.12 | Buy |
| Relative Strength Index (14 RSI): | 49.65 | Sell |
| Chaikin Money Flow: | -199987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (541.81 - 584.93) | Sell |
| Bollinger Bands (100): | (377.57 - 529.47) | Buy |
NQP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 12.11 | Sell |
| 50-day SMA: | 12.09 | Sell |
| 200-day SMA: | 11.41 | Buy |
| 8-day EMA: | 12.07 | Sell |
| 20-day EMA: | 12.09 | Sell |
| 50-day EMA: | 12 | Buy |
| 200-day EMA: | 11.63 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 559.88 | Sell |
| 20-day SMA: | 569.93 | Sell |
| 50-day SMA: | 503.41 | Buy |
| 200-day SMA: | 380.65 | Buy |
| 8-day EMA: | 560.16 | Sell |
| 20-day EMA: | 555.94 | Sell |
| 50-day EMA: | 516.55 | Buy |
| 200-day EMA: | 408.33 | Buy |
Nuveen Pennsylvania Quality Municipal Income Fund Earnings Growth & NQP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.31 per share, and an increase next year of $15.02 per share.
Nuveen Pennsylvania Quality Municipal Income Fund Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||